Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Assets (2016 - 2025)

Historic Return on Assets for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 0.43%.

  • Ocular Therapeutix's Return on Assets fell 800.0% to 0.43% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.43%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.42% for FY2025, which is 500.0% up from last year.
  • According to the latest figures from Q4 2025, Ocular Therapeutix's Return on Assets is 0.43%, which was down 800.0% from 0.57% recorded in Q3 2025.
  • Ocular Therapeutix's Return on Assets' 5-year high stood at 0.22% during Q2 2024, with a 5-year trough of 0.71% in Q2 2023.
  • In the last 5 years, Ocular Therapeutix's Return on Assets had a median value of 0.43% in 2023 and averaged 0.44%.
  • As far as peak fluctuations go, Ocular Therapeutix's Return on Assets surged by 8800bps in 2021, and later crashed by -3000bps in 2025.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Return on Assets stood at 0.4% in 2021, then plummeted by -38bps to 0.55% in 2022, then rose by 21bps to 0.43% in 2023, then rose by 20bps to 0.35% in 2024, then dropped by -24bps to 0.43% in 2025.
  • Its Return on Assets was 0.43% in Q4 2025, compared to 0.57% in Q3 2025 and 0.52% in Q2 2025.